Abstract:OBJECTIVE:To explore the incidence of chromosome 1 abnormality in myelodysplastic syndrome（MDS）to couple its association with clinical presentation and prognosis.METHODS:R- band karyotype analyses were performed in 672 cases of MDS between 2010 and 2013. Clinical data of those with abnormal chromosome l were collected and then analyzed factors affecting the prognosis.RESULTS:Of 672 cases of patients with MDS, chromosome 1 aberration［der（1）, dup（1）, －1 were most frequent］ were found in 41（6.1%）cases. 1q trisomy was found in 18/41（43.9%）cases, and the most common patterns were duplication of the long arm as well as unbalanced translocation with other chromosomes. Of 41 patients with chromosomal 1 abnormality, 32 cases were accompanied with other chromosomal aberration, usually involving 3 or more abnormal chromosomal karyotypes, e.g., chromosome 8, 7 abnormalities. According to IPSS-R scoring system, 19 patients were diagnosed with very high risk, 10 patients high risk, 10 patients intermediate risk and 2 patients low risk MDS. 9 patients transformed into acute leukemia with median transforming time of 7.18（0.56-54.28）months. Median survival of 36 cases after 2010 was 17.48（95% CI 14.38-20.58）months. There were significant differences on median survival between RAEB and non-RAEB groups（χ²=10.398, P=0.001）, and between with more than 3 chromosome abnormalities and with less than 3 groups（χ²=3.939, P=0.047）. RAEB was identified as an independent risk factor for the prognosis of MDS with chromosome 1 abnormality.CONCLUSION:Chromosome 1 aberration was not rare in MDS. 1q trisomy was the most common abnormal karyotype in China, which often accompanied with other chromosomal abnormalities. The prognosis of MDS patients with chromosome 1 abnormality was poor, especially worse in those diagnosed with RAEB-1, RAEB-2 and with more than 3 chromosome abnormality. For patients whose percentage of bone marrow blasts less than 5%, the prognosis of patients with 1q trisomy was better than those without 1q trisomy. RAEB was identified as an independent risk factor for the prognosis of MDS with chromosome 1 abnormality.

Clinical Analysis of 24 Cases of Acute Myeloid Leukemia with 3q Abnormalities

[Cytogenetic and Clinical Analysis of -7/7Q- Abnormalities in Acute Leukemia and Myelodysplastic Syndrome].

Unusual Findings Of Acute Myeloid Leukemia With Inv(3)(Q21q26.2) Or T(3;3)(Q21;Q26.2): A Multicenter Study

Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 1

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

[Clinical and Cytogenetics Studies on Acute Myeloid Leukemia with Abnormality of Chromosome 11].

[Analysis of 32 Cases of Acute Leukemia with Abnormality of Chromosome 7].

[Cytogenetic and Molecular Analysis of 1193 Cases with Chronic Myeloid Leukemia].

Clinical analysis on 15 acute myeloid leukemia patients with 11p15 abnormalities

[Cytogenetic Analysis of 154 Case of Acute Myeloid Leukemia with T(8;21)].

Cytogenetic Profile of De Novo Acute Myeloid Leukemia: a Study Based on 1432 Patients in a Single Institution of China

[Karyotype Analysis of 283 Cases of Myelodysplastic Syndrome].

Clinical and Biological Characteristics of Acute Myeloid Leukemia with 20-29% Blasts: a Retrospective Single-Center Study

Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population

[Clinical and Cytogenetic Study of Chromosome 1 Abnormality in Myelodysplastic Syndrome].

[Clinical Analysis of Myeloid Neoplasms with T (3;21) (Q26;q22)].

[Clinical and Laboratory Investigation of Hematological Malignancy Patients Carrying 3q21q26 Rearrangement].

[Characteristics of Cases with Chromosome 3q21q26 Aberrations].

Clinical and Laboratory Studies on Childhood Acute Leukemia with 11q23 Abnormalities

[Clinical and Molecular Biologic Characteristics of 36 Cases of Leukemia with 11Q23/mll].

Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia